Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.09.2021 | Case report

Ipilimumab/nivolumab

Nephritis and skin reaction: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Paderi A, et al. Article association between immune related adverse events and outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Cancers 13: 1-11, No. 4, 18 Feb 2021. Available from: URL: http://doi.org/10.3390/cancers13040860 Paderi A, et al. Article association between immune related adverse events and outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Cancers 13: 1-11, No. 4, 18 Feb 2021. Available from: URL: http://​doi.​org/​10.​3390/​cancers13040860
Metadaten
Titel
Ipilimumab/nivolumab
Nephritis and skin reaction: 2 case reports
Publikationsdatum
01.09.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-02194-5

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Cotrimoxazole

Case report

Multiple drugs

Case report

Cyclophosphamide